Global Androgen Receptor Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Androgen Receptor Antagonist market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Androgen receptor (AR) is an important target of prostate cancer drugs, and its structure plays an important guiding role in drug development. The androgen receptor consists of 4 structural domains and 8 exons, which are N-terminal binding domain (NTD, exon 1), DNA binding domain (DBD, exon 2-3), hinge region ( HR, exon 4), C-terminal binding domain (LBD, exons 5-8), nuclear localization signal (NLS) is a dichotomous motif contained within exons 3 and 4. The LBD contains a buried hormone-binding pocket (HBP) and a transcriptional activation domain, AF2. AF2 plays an important role in the formation of homodimers, AF2 contains helices 3, 4, 5 and 12 (H3, H4, H5, H12), H12 can change position when ligand binds, when ligand binds to the binding pocket Upon binding, H12 folds back closer to the binding site, preventing ligand disengagement. Non-steroidal AR antagonists avoid the common hormone-like toxic side effects of steroidal AR antagonists, expand clinical applications, and are currently the most commonly used prostate cancer drugs in the United States.
This report is a detailed and comprehensive analysis for global Androgen Receptor Antagonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Androgen Receptor Antagonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Androgen Receptor Antagonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Androgen Receptor Antagonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Androgen Receptor Antagonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Androgen Receptor Antagonist
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Androgen Receptor Antagonist market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc, Sanofi, Astellas Pharma Inc, Pfizer and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Androgen Receptor Antagonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Androgen Receptor Antagonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Androgen Receptor Antagonist, with price, sales, revenue and global market share of Androgen Receptor Antagonist from 2018 to 2023.
Chapter 3, the Androgen Receptor Antagonist competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Androgen Receptor Antagonist breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Androgen Receptor Antagonist market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Androgen Receptor Antagonist.
Chapter 14 and 15, to describe Androgen Receptor Antagonist sales channel, distributors, customers, research findings and conclusion.
Androgen receptor (AR) is an important target of prostate cancer drugs, and its structure plays an important guiding role in drug development. The androgen receptor consists of 4 structural domains and 8 exons, which are N-terminal binding domain (NTD, exon 1), DNA binding domain (DBD, exon 2-3), hinge region ( HR, exon 4), C-terminal binding domain (LBD, exons 5-8), nuclear localization signal (NLS) is a dichotomous motif contained within exons 3 and 4. The LBD contains a buried hormone-binding pocket (HBP) and a transcriptional activation domain, AF2. AF2 plays an important role in the formation of homodimers, AF2 contains helices 3, 4, 5 and 12 (H3, H4, H5, H12), H12 can change position when ligand binds, when ligand binds to the binding pocket Upon binding, H12 folds back closer to the binding site, preventing ligand disengagement. Non-steroidal AR antagonists avoid the common hormone-like toxic side effects of steroidal AR antagonists, expand clinical applications, and are currently the most commonly used prostate cancer drugs in the United States.
This report is a detailed and comprehensive analysis for global Androgen Receptor Antagonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Androgen Receptor Antagonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Androgen Receptor Antagonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Androgen Receptor Antagonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Androgen Receptor Antagonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Androgen Receptor Antagonist
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Androgen Receptor Antagonist market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc, Sanofi, Astellas Pharma Inc, Pfizer and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Androgen Receptor Antagonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- First Generation Inhibitors
- Second Generation Inhibitors
- Prostate Cancer
- Breast Cancer
- Other
- Merck & Co., Inc
- Sanofi
- Astellas Pharma Inc
- Pfizer
- Johnson & Johnson
- Bayer
- Hinova
- Jiangsu Hengrui Pharmaceuticals Co., Ltd
- Kintor Pharma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Androgen Receptor Antagonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Androgen Receptor Antagonist, with price, sales, revenue and global market share of Androgen Receptor Antagonist from 2018 to 2023.
Chapter 3, the Androgen Receptor Antagonist competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Androgen Receptor Antagonist breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Androgen Receptor Antagonist market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Androgen Receptor Antagonist.
Chapter 14 and 15, to describe Androgen Receptor Antagonist sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Androgen Receptor Antagonist
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Androgen Receptor Antagonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 First Generation Inhibitors
1.3.3 Second Generation Inhibitors
1.4 Market Analysis by Application
1.4.1 Overview: Global Androgen Receptor Antagonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Prostate Cancer
1.4.3 Breast Cancer
1.4.4 Other
1.5 Global Androgen Receptor Antagonist Market Size & Forecast
1.5.1 Global Androgen Receptor Antagonist Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Androgen Receptor Antagonist Sales Quantity (2018-2029)
1.5.3 Global Androgen Receptor Antagonist Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck & Co., Inc
2.1.1 Merck & Co., Inc Details
2.1.2 Merck & Co., Inc Major Business
2.1.3 Merck & Co., Inc Androgen Receptor Antagonist Product and Services
2.1.4 Merck & Co., Inc Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck & Co., Inc Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Androgen Receptor Antagonist Product and Services
2.2.4 Sanofi Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 Astellas Pharma Inc
2.3.1 Astellas Pharma Inc Details
2.3.2 Astellas Pharma Inc Major Business
2.3.3 Astellas Pharma Inc Androgen Receptor Antagonist Product and Services
2.3.4 Astellas Pharma Inc Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Astellas Pharma Inc Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Androgen Receptor Antagonist Product and Services
2.4.4 Pfizer Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Androgen Receptor Antagonist Product and Services
2.5.4 Johnson & Johnson Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Androgen Receptor Antagonist Product and Services
2.6.4 Bayer Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bayer Recent Developments/Updates
2.7 Hinova
2.7.1 Hinova Details
2.7.2 Hinova Major Business
2.7.3 Hinova Androgen Receptor Antagonist Product and Services
2.7.4 Hinova Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hinova Recent Developments/Updates
2.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd
2.8.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
2.8.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
2.8.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product and Services
2.8.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
2.9 Kintor Pharma
2.9.1 Kintor Pharma Details
2.9.2 Kintor Pharma Major Business
2.9.3 Kintor Pharma Androgen Receptor Antagonist Product and Services
2.9.4 Kintor Pharma Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kintor Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANDROGEN RECEPTOR ANTAGONIST BY MANUFACTURER
3.1 Global Androgen Receptor Antagonist Sales Quantity by Manufacturer (2018-2023)
3.2 Global Androgen Receptor Antagonist Revenue by Manufacturer (2018-2023)
3.3 Global Androgen Receptor Antagonist Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Androgen Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Androgen Receptor Antagonist Manufacturer Market Share in 2022
3.4.2 Top 6 Androgen Receptor Antagonist Manufacturer Market Share in 2022
3.5 Androgen Receptor Antagonist Market: Overall Company Footprint Analysis
3.5.1 Androgen Receptor Antagonist Market: Region Footprint
3.5.2 Androgen Receptor Antagonist Market: Company Product Type Footprint
3.5.3 Androgen Receptor Antagonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Androgen Receptor Antagonist Market Size by Region
4.1.1 Global Androgen Receptor Antagonist Sales Quantity by Region (2018-2029)
4.1.2 Global Androgen Receptor Antagonist Consumption Value by Region (2018-2029)
4.1.3 Global Androgen Receptor Antagonist Average Price by Region (2018-2029)
4.2 North America Androgen Receptor Antagonist Consumption Value (2018-2029)
4.3 Europe Androgen Receptor Antagonist Consumption Value (2018-2029)
4.4 Asia-Pacific Androgen Receptor Antagonist Consumption Value (2018-2029)
4.5 South America Androgen Receptor Antagonist Consumption Value (2018-2029)
4.6 Middle East and Africa Androgen Receptor Antagonist Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
5.2 Global Androgen Receptor Antagonist Consumption Value by Type (2018-2029)
5.3 Global Androgen Receptor Antagonist Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
6.2 Global Androgen Receptor Antagonist Consumption Value by Application (2018-2029)
6.3 Global Androgen Receptor Antagonist Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
7.2 North America Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
7.3 North America Androgen Receptor Antagonist Market Size by Country
7.3.1 North America Androgen Receptor Antagonist Sales Quantity by Country (2018-2029)
7.3.2 North America Androgen Receptor Antagonist Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
8.2 Europe Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
8.3 Europe Androgen Receptor Antagonist Market Size by Country
8.3.1 Europe Androgen Receptor Antagonist Sales Quantity by Country (2018-2029)
8.3.2 Europe Androgen Receptor Antagonist Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Androgen Receptor Antagonist Market Size by Region
9.3.1 Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Androgen Receptor Antagonist Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
10.2 South America Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
10.3 South America Androgen Receptor Antagonist Market Size by Country
10.3.1 South America Androgen Receptor Antagonist Sales Quantity by Country (2018-2029)
10.3.2 South America Androgen Receptor Antagonist Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Androgen Receptor Antagonist Market Size by Country
11.3.1 Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Androgen Receptor Antagonist Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Androgen Receptor Antagonist Market Drivers
12.2 Androgen Receptor Antagonist Market Restraints
12.3 Androgen Receptor Antagonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Androgen Receptor Antagonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of Androgen Receptor Antagonist
13.3 Androgen Receptor Antagonist Production Process
13.4 Androgen Receptor Antagonist Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Androgen Receptor Antagonist Typical Distributors
14.3 Androgen Receptor Antagonist Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Androgen Receptor Antagonist
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Androgen Receptor Antagonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 First Generation Inhibitors
1.3.3 Second Generation Inhibitors
1.4 Market Analysis by Application
1.4.1 Overview: Global Androgen Receptor Antagonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Prostate Cancer
1.4.3 Breast Cancer
1.4.4 Other
1.5 Global Androgen Receptor Antagonist Market Size & Forecast
1.5.1 Global Androgen Receptor Antagonist Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Androgen Receptor Antagonist Sales Quantity (2018-2029)
1.5.3 Global Androgen Receptor Antagonist Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck & Co., Inc
2.1.1 Merck & Co., Inc Details
2.1.2 Merck & Co., Inc Major Business
2.1.3 Merck & Co., Inc Androgen Receptor Antagonist Product and Services
2.1.4 Merck & Co., Inc Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck & Co., Inc Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Androgen Receptor Antagonist Product and Services
2.2.4 Sanofi Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 Astellas Pharma Inc
2.3.1 Astellas Pharma Inc Details
2.3.2 Astellas Pharma Inc Major Business
2.3.3 Astellas Pharma Inc Androgen Receptor Antagonist Product and Services
2.3.4 Astellas Pharma Inc Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Astellas Pharma Inc Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Androgen Receptor Antagonist Product and Services
2.4.4 Pfizer Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Androgen Receptor Antagonist Product and Services
2.5.4 Johnson & Johnson Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Androgen Receptor Antagonist Product and Services
2.6.4 Bayer Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bayer Recent Developments/Updates
2.7 Hinova
2.7.1 Hinova Details
2.7.2 Hinova Major Business
2.7.3 Hinova Androgen Receptor Antagonist Product and Services
2.7.4 Hinova Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hinova Recent Developments/Updates
2.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd
2.8.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
2.8.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
2.8.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product and Services
2.8.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
2.9 Kintor Pharma
2.9.1 Kintor Pharma Details
2.9.2 Kintor Pharma Major Business
2.9.3 Kintor Pharma Androgen Receptor Antagonist Product and Services
2.9.4 Kintor Pharma Androgen Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kintor Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANDROGEN RECEPTOR ANTAGONIST BY MANUFACTURER
3.1 Global Androgen Receptor Antagonist Sales Quantity by Manufacturer (2018-2023)
3.2 Global Androgen Receptor Antagonist Revenue by Manufacturer (2018-2023)
3.3 Global Androgen Receptor Antagonist Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Androgen Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Androgen Receptor Antagonist Manufacturer Market Share in 2022
3.4.2 Top 6 Androgen Receptor Antagonist Manufacturer Market Share in 2022
3.5 Androgen Receptor Antagonist Market: Overall Company Footprint Analysis
3.5.1 Androgen Receptor Antagonist Market: Region Footprint
3.5.2 Androgen Receptor Antagonist Market: Company Product Type Footprint
3.5.3 Androgen Receptor Antagonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Androgen Receptor Antagonist Market Size by Region
4.1.1 Global Androgen Receptor Antagonist Sales Quantity by Region (2018-2029)
4.1.2 Global Androgen Receptor Antagonist Consumption Value by Region (2018-2029)
4.1.3 Global Androgen Receptor Antagonist Average Price by Region (2018-2029)
4.2 North America Androgen Receptor Antagonist Consumption Value (2018-2029)
4.3 Europe Androgen Receptor Antagonist Consumption Value (2018-2029)
4.4 Asia-Pacific Androgen Receptor Antagonist Consumption Value (2018-2029)
4.5 South America Androgen Receptor Antagonist Consumption Value (2018-2029)
4.6 Middle East and Africa Androgen Receptor Antagonist Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
5.2 Global Androgen Receptor Antagonist Consumption Value by Type (2018-2029)
5.3 Global Androgen Receptor Antagonist Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
6.2 Global Androgen Receptor Antagonist Consumption Value by Application (2018-2029)
6.3 Global Androgen Receptor Antagonist Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
7.2 North America Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
7.3 North America Androgen Receptor Antagonist Market Size by Country
7.3.1 North America Androgen Receptor Antagonist Sales Quantity by Country (2018-2029)
7.3.2 North America Androgen Receptor Antagonist Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
8.2 Europe Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
8.3 Europe Androgen Receptor Antagonist Market Size by Country
8.3.1 Europe Androgen Receptor Antagonist Sales Quantity by Country (2018-2029)
8.3.2 Europe Androgen Receptor Antagonist Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Androgen Receptor Antagonist Market Size by Region
9.3.1 Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Androgen Receptor Antagonist Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
10.2 South America Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
10.3 South America Androgen Receptor Antagonist Market Size by Country
10.3.1 South America Androgen Receptor Antagonist Sales Quantity by Country (2018-2029)
10.3.2 South America Androgen Receptor Antagonist Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Androgen Receptor Antagonist Market Size by Country
11.3.1 Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Androgen Receptor Antagonist Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Androgen Receptor Antagonist Market Drivers
12.2 Androgen Receptor Antagonist Market Restraints
12.3 Androgen Receptor Antagonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Androgen Receptor Antagonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of Androgen Receptor Antagonist
13.3 Androgen Receptor Antagonist Production Process
13.4 Androgen Receptor Antagonist Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Androgen Receptor Antagonist Typical Distributors
14.3 Androgen Receptor Antagonist Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Androgen Receptor Antagonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Androgen Receptor Antagonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc Major Business
Table 5. Merck & Co., Inc Androgen Receptor Antagonist Product and Services
Table 6. Merck & Co., Inc Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck & Co., Inc Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Androgen Receptor Antagonist Product and Services
Table 11. Sanofi Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 14. Astellas Pharma Inc Major Business
Table 15. Astellas Pharma Inc Androgen Receptor Antagonist Product and Services
Table 16. Astellas Pharma Inc Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Astellas Pharma Inc Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Androgen Receptor Antagonist Product and Services
Table 21. Pfizer Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Androgen Receptor Antagonist Product and Services
Table 26. Johnson & Johnson Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Bayer Basic Information, Manufacturing Base and Competitors
Table 29. Bayer Major Business
Table 30. Bayer Androgen Receptor Antagonist Product and Services
Table 31. Bayer Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bayer Recent Developments/Updates
Table 33. Hinova Basic Information, Manufacturing Base and Competitors
Table 34. Hinova Major Business
Table 35. Hinova Androgen Receptor Antagonist Product and Services
Table 36. Hinova Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hinova Recent Developments/Updates
Table 38. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
Table 40. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product and Services
Table 41. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 43. Kintor Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Kintor Pharma Major Business
Table 45. Kintor Pharma Androgen Receptor Antagonist Product and Services
Table 46. Kintor Pharma Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kintor Pharma Recent Developments/Updates
Table 48. Global Androgen Receptor Antagonist Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Androgen Receptor Antagonist Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Androgen Receptor Antagonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Androgen Receptor Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Androgen Receptor Antagonist Production Site of Key Manufacturer
Table 53. Androgen Receptor Antagonist Market: Company Product Type Footprint
Table 54. Androgen Receptor Antagonist Market: Company Product Application Footprint
Table 55. Androgen Receptor Antagonist New Market Entrants and Barriers to Market Entry
Table 56. Androgen Receptor Antagonist Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Androgen Receptor Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Androgen Receptor Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Androgen Receptor Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Androgen Receptor Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Androgen Receptor Antagonist Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Androgen Receptor Antagonist Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Androgen Receptor Antagonist Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Androgen Receptor Antagonist Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Androgen Receptor Antagonist Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Androgen Receptor Antagonist Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Androgen Receptor Antagonist Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Androgen Receptor Antagonist Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Androgen Receptor Antagonist Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Androgen Receptor Antagonist Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Androgen Receptor Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Androgen Receptor Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Androgen Receptor Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Androgen Receptor Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Androgen Receptor Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Androgen Receptor Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Androgen Receptor Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Androgen Receptor Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Androgen Receptor Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Androgen Receptor Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Androgen Receptor Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Androgen Receptor Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Androgen Receptor Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Androgen Receptor Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Androgen Receptor Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Androgen Receptor Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Androgen Receptor Antagonist Raw Material
Table 116. Key Manufacturers of Androgen Receptor Antagonist Raw Materials
Table 117. Androgen Receptor Antagonist Typical Distributors
Table 118. Androgen Receptor Antagonist Typical Customers
Table 1. Global Androgen Receptor Antagonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Androgen Receptor Antagonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc Major Business
Table 5. Merck & Co., Inc Androgen Receptor Antagonist Product and Services
Table 6. Merck & Co., Inc Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck & Co., Inc Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Androgen Receptor Antagonist Product and Services
Table 11. Sanofi Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 14. Astellas Pharma Inc Major Business
Table 15. Astellas Pharma Inc Androgen Receptor Antagonist Product and Services
Table 16. Astellas Pharma Inc Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Astellas Pharma Inc Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Androgen Receptor Antagonist Product and Services
Table 21. Pfizer Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Androgen Receptor Antagonist Product and Services
Table 26. Johnson & Johnson Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Bayer Basic Information, Manufacturing Base and Competitors
Table 29. Bayer Major Business
Table 30. Bayer Androgen Receptor Antagonist Product and Services
Table 31. Bayer Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bayer Recent Developments/Updates
Table 33. Hinova Basic Information, Manufacturing Base and Competitors
Table 34. Hinova Major Business
Table 35. Hinova Androgen Receptor Antagonist Product and Services
Table 36. Hinova Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hinova Recent Developments/Updates
Table 38. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
Table 40. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product and Services
Table 41. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 43. Kintor Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Kintor Pharma Major Business
Table 45. Kintor Pharma Androgen Receptor Antagonist Product and Services
Table 46. Kintor Pharma Androgen Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kintor Pharma Recent Developments/Updates
Table 48. Global Androgen Receptor Antagonist Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Androgen Receptor Antagonist Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Androgen Receptor Antagonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Androgen Receptor Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Androgen Receptor Antagonist Production Site of Key Manufacturer
Table 53. Androgen Receptor Antagonist Market: Company Product Type Footprint
Table 54. Androgen Receptor Antagonist Market: Company Product Application Footprint
Table 55. Androgen Receptor Antagonist New Market Entrants and Barriers to Market Entry
Table 56. Androgen Receptor Antagonist Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Androgen Receptor Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Androgen Receptor Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Androgen Receptor Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Androgen Receptor Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Androgen Receptor Antagonist Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Androgen Receptor Antagonist Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Androgen Receptor Antagonist Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Androgen Receptor Antagonist Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Androgen Receptor Antagonist Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Androgen Receptor Antagonist Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Androgen Receptor Antagonist Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Androgen Receptor Antagonist Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Androgen Receptor Antagonist Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Androgen Receptor Antagonist Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Androgen Receptor Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Androgen Receptor Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Androgen Receptor Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Androgen Receptor Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Androgen Receptor Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Androgen Receptor Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Androgen Receptor Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Androgen Receptor Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Androgen Receptor Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Androgen Receptor Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Androgen Receptor Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Androgen Receptor Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Androgen Receptor Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Androgen Receptor Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Androgen Receptor Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Androgen Receptor Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Androgen Receptor Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Androgen Receptor Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Androgen Receptor Antagonist Raw Material
Table 116. Key Manufacturers of Androgen Receptor Antagonist Raw Materials
Table 117. Androgen Receptor Antagonist Typical Distributors
Table 118. Androgen Receptor Antagonist Typical Customers
LIST OF FIGURES
Figure 1. Androgen Receptor Antagonist Picture
Figure 2. Global Androgen Receptor Antagonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Androgen Receptor Antagonist Consumption Value Market Share by Type in 2022
Figure 4. First Generation Inhibitors Examples
Figure 5. Second Generation Inhibitors Examples
Figure 6. Global Androgen Receptor Antagonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Androgen Receptor Antagonist Consumption Value Market Share by Application in 2022
Figure 8. Prostate Cancer Examples
Figure 9. Breast Cancer Examples
Figure 10. Other Examples
Figure 11. Global Androgen Receptor Antagonist Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Androgen Receptor Antagonist Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Androgen Receptor Antagonist Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Androgen Receptor Antagonist Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Androgen Receptor Antagonist Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Androgen Receptor Antagonist Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Androgen Receptor Antagonist by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Androgen Receptor Antagonist Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Androgen Receptor Antagonist Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Androgen Receptor Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Androgen Receptor Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Androgen Receptor Antagonist Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Androgen Receptor Antagonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Androgen Receptor Antagonist Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Androgen Receptor Antagonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Androgen Receptor Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Androgen Receptor Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Androgen Receptor Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Androgen Receptor Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Androgen Receptor Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Androgen Receptor Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 53. China Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Androgen Receptor Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Androgen Receptor Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Androgen Receptor Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Androgen Receptor Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Androgen Receptor Antagonist Market Drivers
Figure 74. Androgen Receptor Antagonist Market Restraints
Figure 75. Androgen Receptor Antagonist Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Androgen Receptor Antagonist in 2022
Figure 78. Manufacturing Process Analysis of Androgen Receptor Antagonist
Figure 79. Androgen Receptor Antagonist Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Androgen Receptor Antagonist Picture
Figure 2. Global Androgen Receptor Antagonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Androgen Receptor Antagonist Consumption Value Market Share by Type in 2022
Figure 4. First Generation Inhibitors Examples
Figure 5. Second Generation Inhibitors Examples
Figure 6. Global Androgen Receptor Antagonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Androgen Receptor Antagonist Consumption Value Market Share by Application in 2022
Figure 8. Prostate Cancer Examples
Figure 9. Breast Cancer Examples
Figure 10. Other Examples
Figure 11. Global Androgen Receptor Antagonist Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Androgen Receptor Antagonist Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Androgen Receptor Antagonist Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Androgen Receptor Antagonist Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Androgen Receptor Antagonist Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Androgen Receptor Antagonist Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Androgen Receptor Antagonist by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Androgen Receptor Antagonist Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Androgen Receptor Antagonist Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Androgen Receptor Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Androgen Receptor Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Androgen Receptor Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Androgen Receptor Antagonist Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Androgen Receptor Antagonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Androgen Receptor Antagonist Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Androgen Receptor Antagonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Androgen Receptor Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Androgen Receptor Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Androgen Receptor Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Androgen Receptor Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Androgen Receptor Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Androgen Receptor Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 53. China Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Androgen Receptor Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Androgen Receptor Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Androgen Receptor Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Androgen Receptor Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Androgen Receptor Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Androgen Receptor Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Androgen Receptor Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Androgen Receptor Antagonist Market Drivers
Figure 74. Androgen Receptor Antagonist Market Restraints
Figure 75. Androgen Receptor Antagonist Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Androgen Receptor Antagonist in 2022
Figure 78. Manufacturing Process Analysis of Androgen Receptor Antagonist
Figure 79. Androgen Receptor Antagonist Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
